Tag:
Civitas
Latest Headlines
Latest Headlines
Civitas' inhaled L-dopa Parkinson's treatment passes Phase I
Civitas Therapeutics generated positive top line results in a Phase I trial of CVT-301, its inhaled version of L-dopa to treat Parkinson's disease-related tremors. The drug, which is ingested through
Civitas gains Michael J. Fox Foundation funding for inhaled Parkinson's treatment trials
Civitas Therapeutics has secured new funding from The Michael J. Fox Foundation for Parkinson's Research, which will support clinical testing of its inhaled Parkinson's therapy through the...
